Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- or second-line treatment in advanced malignant melanoma: a trial of the EORTC Clinical Studies Group. (Record no. 10616684)

MARC details
000 -LEADER
fixed length control field 01636 a2200493 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513202330.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200002s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0960-8931
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/00008390-199912000-00011
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Cure, H
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20000229
245 00 - TITLE STATEMENT
Title Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- or second-line treatment in advanced malignant melanoma: a trial of the EORTC Clinical Studies Group.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Melanoma research
Date of publication, distribution, etc. Dec 1999
300 ## - PHYSICAL DESCRIPTION
Extent 607-10 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dacarbazine
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Staging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nitrosourea Compounds
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Souteyrand, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ouabdesselam, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roche, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ravaud, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name D'incan, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Viens, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fargeot, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lentz, M A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fumoleau, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hanauske, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chollet, P
773 0# - HOST ITEM ENTRY
Title Melanoma research
Related parts vol. 9
-- no. 6
-- p. 607-10
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/00008390-199912000-00011">https://doi.org/10.1097/00008390-199912000-00011</a>
Public note Available from publisher's website

No items available.